C12P   1/00  \	0	0	4B064	C12P   1/00	469	ʪޤϹǤѤƤΥ롼ףãУãУʬवʤʪޤʪ¤ʪޤϹǤѤƤβʪޤʪ¤ˡ̡Σ	Preparation of compounds or compositions, not provided for in groups C12P 3/00-C12P 39/00, by using micro-organisms or enzymes; General processes for the preparation of compounds or compositions by using micro-organisms or enzymes [3]
C12P   1/00  A	0	0	4B064	C12P   1/00	448	ʬˤ	Using enzyme decomposition
C12P   1/00  Z	0	0	4B064	C12P   1/00	957	¾Τ	Others
C12P   1/02  \	1	1	4B064	C12P   1/02	448	λѤˤΡΣ	by using fungi [3]
C12P   1/02  A	1	0	4B064	C12P   1/02	310	ͳιʪ	Antibiotics (of mould origin)
C12P   1/02  B	1	0	4B064	C12P   1/02	164	ôҶͳιʪ	Antibiotics (of basidiomycete origin)
C12P   1/02  C	1	0	4B064	C12P   1/02	105	Դͳιʪ	Antibiotics (of  Fungi Imperfecti origin)
C12P   1/02  D	1	0	4B064	C12P   1/02	59	ͳιʪ	Antibiotics (of enzyme origin)
C12P   1/02  Z	1	0	4B064	C12P   1/02	492	¾Τ	Others
C12P   1/04  \	1	1	4B064	C12P   1/04	563	ٶݤλѤˤΡΣ	by using bacteria [3]
C12P   1/04  A	1	0	4B064	C12P   1/04	513	ʪ	Antibiotics
C12P   1/04  Z	1	0	4B064	C12P   1/04	727	¾Τ	Others
C12P   1/06  \	1	1	4B064	C12P   1/06	771	ݤλѤˤΡΣ	by using actinomycetales [3]
C12P   1/06  A	1	0	4B064	C12P   1/06	1698	ʪ	Antibiotics
C12P   1/06  Z	1	0	4B064	C12P   1/06	188	¾Τ	Others
C12P   3/00  \	0	0	4B064	C12P   3/00	160	úǤ̵ʪޤϸǤ¤Σ	Preparation of elements or inorganic compounds except carbon dioxide [3]
C12P   3/00  A	0	0	4B064	C12P   3/00	90	Хƥꥢ꡼󥰤ˤ	From bacteria leaching
C12P   3/00  Z	0	0	4B064	C12P   3/00	458	¾Τ	Others
C12P   5/00  \	0	0	4B064	C12P   5/00	336	úǤ¤Σ	Preparation of hydrocarbons [3]
C12P   5/02  \	1	1	4B064	C12P   5/02	690	ļΤΡΣ	acyclic [3]
C12P   7/00  \	0	0	4B064	C12P   7/00	210	ǸҤޤͭʪ¤Σ	Preparation of oxygen-containing organic compounds [3]
C12P   7/02  \	1	1	4B064	C12P   7/02	709	ͭΡΣ	containing a hydroxy group [3]
C12P   7/04  \	2	2	4B064	C12P   7/04	625	ļΤΡΣ	acyclic [3]
C12P   7/06  \	3	3	4B064	C12P   7/06	1578	Ρ롤ʤΤΡΣ	Ethanol, i.e. non-beverage [3]
C12P   7/08  \	4	4	4B064	C12P   7/08	399	ʪȤƤޤѴʪޤϥʪδ¤Σ	produced as by-product or from waste or cellulosic material substrate [3]
C12P   7/10  \	5	5	4B064	C12P   7/10	500	ʪޤΣ	substrate containing cellulosic material [3]
C12P   7/12  \	5	5	4B064	C12P   7/12	11	βѱդޤϴѴʪޤΣ	substrate containing sulfite waste liquor or citrus waste [3]
C12P   7/14  \	4	4	4B064	C12P   7/14	23	¿ȯڡʪ¿ʷޤʪκƻѡΣ	Multiple stages of fermentation; Multiple types of micro-organisms or reuse for micro-organisms [3]
C12P   7/16  \	3	3	4B064	C12P   7/16	339	֥ΡΣ	Butanols [3]
C12P   7/18  \	3	3	4B064	C12P   7/18	754	¿륳Σ	polyhydric [3]
C12P   7/20  \	4	4	4B064	C12P   7/20	108	ꥻΣ	Glycerol [3]
C12P   7/22  \	2	2	4B064	C12P   7/22	710	˧²ΤΡΣ	aromatic [3]
C12P   7/24  \	1	1	4B064	C12P   7/24	366	ܥ˥ޤΡΣ	containing a carbonyl group [3]
C12P   7/26  \	2	2	4B064	C12P   7/26	569	ȥΣ	Ketones [3]
C12P   7/28  \	3	3	4B064	C12P   7/28	176	ȥޤʪΣ	Acetone-containing products [3]
C12P   7/30  \	4	4	4B064	C12P   7/30	3	ʳ̵ʪޤ¤ΡΣ	produced from substrate containing inorganic compounds other than water [3]
C12P   7/32  \	4	4	4B064	C12P   7/32	0	̵Ǹޤ¤ΡΣ	produced from substrate containing inorganic nitrogen source [3]
C12P   7/34  \	4	4	4B064	C12P   7/34	1	ǸȤޤ¤ΡΣ	produced from substrate containing protein as nitrogen source [3]
C12P   7/36  \	4	4	4B064	C12P   7/36	5	ʪޤϹޤ¤ΡΣ	produced from substrate containing grain or cereal material [3]
C12P   7/38  \	3	3	4B064	C12P   7/38	44	ڥ󥿥Υޤϥڥ󥿥ޤʪΣ	Cyclopentanone- or cyclopentadione- containing products [3]
C12P   7/40  \	1	1	4B064	C12P   7/40	1244	ܥޤΡΣ	containing a carboxyl group [3]
C12P   7/42  \	2	2	4B064	C12P   7/42	1193	ҥɥܥΣ	Hydroxy carboxylic acids [3]
C12P   7/44  \	2	2	4B064	C12P   7/44	510	ݥꥫܥΣ	Polycarboxylic acids [3]
C12P   7/46  \	3	3	4B064	C12P   7/46	563	ʲúǸҤĥܥ㡥եޥޥ쥤Σ	Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid [3]
C12P   7/48  \	3	3	4B064	C12P   7/48	252	ȥꥫܥ㡥Σ	Tricarboxylic acids, e.g. citric acid [3]
C12P   7/50  \	3	3	4B064	C12P   7/50	170	ȴĤΡ㡥ȥ륿Σ	having keto groups, e.g. 2-ketoglutaric acid [3]
C12P   7/52  \	2	2	4B064	C12P   7/52	239	ץԥΣ	Propionic acid; Butyric acids [3]
C12P   7/54  \	2	2	4B064	C12P   7/54	292	ݻΣ	Acetic acid [3]
C12P   7/56  \	2	2	4B064	C12P   7/56	799	Σ	Lactic acid [3]
C12P   7/58  \	2	2	4B064	C12P   7/58	175	ɥȥɥޤʥãУˡΣ	Aldonic, ketoaldonic or saccharic acids (uronic acids C12P 19/00) [3]
C12P   7/60  \	3	3	4B064	C12P   7/60	90	ȥΣ	2-Ketogulonic acid [3]
C12P   7/62  \	1	1	4B064	C12P   7/62	2063	ܥƥΣ	Carboxylic acid esters [3, 2006.01, 2022.01]
C12P   7/625  \	2	2	4B064	C12P   7/625	659	ҥɥܥΥݥꥨƥΣ	Polyesters of hydroxy carboxylic acids [2022.01]
C12P   7/64  \	1	1	4B064	C12P   7/64	2452	áƥ뷿ûʤܥϢ³Ʒ礹뺿˾ʤȤ⣷ĤúǸҤޤΡޤϻáΣ	Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats [3, 2006.01, 2022.01]
C12P   7/6409  \	2	2	4B064	C12P   7/6409	278	ûΣ	Fatty acids [2022.01]
C12P   7/6418  \	3	3	4B064	C12P   7/6418	190	ûƥβÿʬˤΡΣ	by hydrolysis of fatty acid esters [2022.01]
C12P   7/6427  \	3	3	4B064	C12P   7/6427	448	¿˰»ûΣУգƣϡʤúǹʤˣʾŷĤΡΣ	Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone [2022.01]
C12P   7/6431  \	4	4	4B064	C12P   7/6431	43	ΡΣΣϡϡΣ	Linoleic acids [18:2[n-6]] [2022.01]
C12P   7/6432  \	4	4	4B064	C12P   7/6432	107	ڥ󥿥ΣţУϡΣ	Eicosapentaenoic acids [EPA] [2022.01]
C12P   7/6434  \	4	4	4B064	C12P   7/6434	142	ɥإΣģȣϡΣ	Docosahexenoic acids [DHA] [2022.01]
C12P   7/6436  \	2	2	4B064	C12P   7/6436	180	ûƥΣ	Fatty acid esters [2022.01]
C12P   7/6445  \	3	3	4B064	C12P   7/6445	126	ꥻɡΣ	Glycerides [2022.01]
C12P   7/6454  \	4	4	4B064	C12P   7/6454	122	ƥ벽ˤΡΣ	by esterification [2022.01]
C12P   7/6458  \	4	4	4B064	C12P   7/6458	174	ƥžܤˤΡ㡥ƥ򴹡ƥִ륳ʬޤϻʬΣ	by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis [2022.01]
C12P   7/6463  \	4	4	4B064	C12P   7/6463	425	ꥻɤʪΡ㡥ñ˦Σ	obtained from glyceride producing microorganisms, e.g. single cell oil [2022.01]
C12P   7/6472  \	4	4	4B064	C12P   7/6472	523	¿˰»ûΣУգƣϻĴͭΡʤúǹʤˣʾŷĤΡΣ	containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone [2022.01]
C12P   7/6481  \	4	4	4B064	C12P   7/6481	55	ۥۥꥻɡúǿ̤ΥܥͭۥۥꥻɣãУˡΣ	Phosphoglycerides (phosphoglycerides having carboxylic acids with less than seven carbon atoms C12P 7/62) [2022.01]
C12P   7/649  \	3	3	4B064	C12P   7/649	134	Хǥ롤ʤû륭륨ƥΣ	Biodiesel, i.e. fatty acid alkyl esters [2022.01]
C12P   7/66  \	1	1	4B064	C12P   7/66	158	Υɹ¤ĤΡΣ	containing the quinoid structure [3]
C12P   7/66  A	1	0	4B064	C12P   7/66	222	ǣ	Coenzyme Q
C12P   7/66  Z	1	0	4B064	C12P   7/66	134	¾Τ	Others
C12P   9/00  \	0	0	4B064	C12P   9/00	406	°ҡޤϣȡΡáϡӤޤϥϥʳθҤޤͭʪ¤Σ	Preparation of organic compounds containing a metal or atom other than H, N, C, O, S, or halogen [3]
C12P  11/00  \	0	0	4B064	C12P  11/00	265	βҤޤͭʪ¤Σ	Preparation of sulfur-containing organic compounds [3]
C12P  13/00  \	0	0	4B064	C12P  13/00	1694	ǸҤޤͭʪ¤Σ	Preparation of nitrogen-containing organic compounds [3]
C12P  13/02  \	1	1	4B064	C12P  13/02	914	ߥɡ㡥ե˥Σ	Amides, e.g. chloramphenicol [3]
C12P  13/04  \	1	1	4B064	C12P  13/04	1657	ޤϦ¡ߥλΣ	Alpha- or beta-amino acids [3]
C12P  13/06  \	2	2	4B064	C12P  13/06	325	˥󡨥󡨥󡨥󡨥ۥ⥻Σ	Alanine; Leucine; Isoleucine; Serine; Homoserine [3]
C12P  13/06  A	2	0	4B064	C12P  13/06	185	˥	Alanine
C12P  13/06  B	2	0	4B064	C12P  13/06	145		Leucine
C12P  13/06  C	2	0	4B064	C12P  13/06	216		Isoleucine
C12P  13/06  D	2	0	4B064	C12P  13/06	165		Serine
C12P  13/06  E	2	0	4B064	C12P  13/06	55	ۥ⥻	Homeserine
C12P  13/06  Z	2	0	4B064	C12P  13/06	44	¾Τ	Others
C12P  13/08  \	2	2	4B064	C12P  13/08	466	ꥸ󡨥ߥΥԥȥ쥪˥󡨥ХΣ	Lysine; Diaminopimelic acid; Threonine; Valine [3]
C12P  13/08  A	2	0	4B064	C12P  13/08	589	ꥸ	Lysine
C12P  13/08  B	2	0	4B064	C12P  13/08	18	ߥΥԥ	Diaminopimelic acid
C12P  13/08  C	2	0	4B064	C12P  13/08	336	ȥ쥪˥	Threonine
C12P  13/08  D	2	0	4B064	C12P  13/08	178	Х	Valine
C12P  13/08  Z	2	0	4B064	C12P  13/08	34	¾Τ	Others
C12P  13/10  \	2	2	4B064	C12P  13/10	74	ȥ󡨥륮˥󡨥˥Σ	Citrulline; Arginine; Ornithine [3]
C12P  13/10  A	2	0	4B064	C12P  13/10	57	ȥ	Citrulline
C12P  13/10  B	2	0	4B064	C12P  13/10	187	륮˥	Arginine
C12P  13/10  C	2	0	4B064	C12P  13/10	94	˥	Ornithine
C12P  13/10  Z	2	0	4B064	C12P  13/10	9	¾Τ	Others
C12P  13/12  \	2	2	4B064	C12P  13/12	82	˥󡨥ƥ󡨥Σ	Methionine; Cysteine; Cystine [3]
C12P  13/12  A	2	0	4B064	C12P  13/12	206	˥	Methionine
C12P  13/12  B	2	0	4B064	C12P  13/12	177	ƥ	Cycteine
C12P  13/12  C	2	0	4B064	C12P  13/12	44		Cyctine
C12P  13/12  Z	2	0	4B064	C12P  13/12	55	¾Τ	Others
C12P  13/14  \	2	2	4B064	C12P  13/14	296	륿ߥ륿ߥΣ	Glutamic acid; Glutamine [3]
C12P  13/14  A	2	0	4B064	C12P  13/14	346		Productive bacteria
C12P  13/14  B	2	0	4B064	C12P  13/14	124	žãθ	Conversion, CN source
C12P  13/14  C	2	0	4B064	C12P  13/14	109	ʬΥ	Separation, refining
C12P  13/14  D	2	0	4B064	C12P  13/14	82	ź	Added medicinals
C12P  13/14  E	2	0	4B064	C12P  13/14	86	ܾ	Culture condition
C12P  13/14  Z	2	0	4B064	C12P  13/14	55	¾Τ	Others
C12P  13/16  \	3	3	4B064	C12P  13/16	44	̳ޡûޤϻûƥ롤ʤܥޤϥܥƥϢ³Ʒ礹뺿˾ʤȤ⣷ĤúǸҤͭΡѤΡΣ	using surfactants, fatty acids or fatty acid esters, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group or a carboxyl ester group [3]
C12P  13/18  \	3	3	4B064	C12P  13/18	52	ӥޤϤͶƳΤѤΡΣ	using biotin or its derivatives [3]
C12P  13/20  \	2	2	4B064	C12P  13/20	223	ѥ饮ѥ饮Σ	Aspartic acid; Asparagine [3]
C12P  13/22  \	2	2	4B064	C12P  13/22	645	ȥץȥե󡨥󡨥ե˥륢˥󡨣ҥɥե˥륢˥Σ	Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine [3]
C12P  13/22  A	2	0	4B064	C12P  13/22	375	ȥץȥե	Tryptophan
C12P  13/22  B	2	0	4B064	C12P  13/22	110		Tyrosine
C12P  13/22  C	2	0	4B064	C12P  13/22	393	ե˥륢˥	Phenylalanine
C12P  13/22  D	2	0	4B064	C12P  13/22	47	ݥҥɥե˥륢˥	3.4-Dihydroxyphenylalanine
C12P  13/22  Z	2	0	4B064	C12P  13/22	27	¾Τ	Others
C12P  13/24  \	2	2	4B064	C12P  13/24	119	ץ󡨥ҥɥץ󡨥ҥΣ	Proline; Hydroxyproline; Histidine [3]
C12P  13/24  A	2	0	4B064	C12P  13/24	125	ץ󡨥ҥɥץ	Proline; Hydroxyproline
C12P  13/24  C	2	0	4B064	C12P  13/24	111	ҥ	Histidine
C12P  13/24  Z	2	0	4B064	C12P  13/24	14	¾Τ	Others
C12P  15/00  \	0	0	4B064	C12P  15/00	194	İʾν̹úǴĤޤͭʪ¤Σ	Preparation of compounds containing at least three condensed carbocyclic rings [3]
C12P  17/00  \	0	0	4B064	C12P  17/00	186	۹ึҤȤƣϡΡӡӣ塤ޤϣԣΤߤʣǴļʪ¤ʣãУãУͥˡΣ	Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms (C12P 13/04-C12P 13/24 take precedence) [3]
C12P  17/02  \	1	1	4B064	C12P  17/02	464	۹ึҤȤƻǸҤΤߤΤΡΣ	Oxygen as only ring hetero atoms [3]
C12P  17/04  \	2	2	4B064	C12P  17/04	545	ĤĤΡ㡥ꥻեӥΣ	containing a five-membered hetero ring, e.g. griseofulvin [3]
C12P  17/06  \	2	2	4B064	C12P  17/06	911	ĤĤΡ㡥ե륪쥻Σ	containing a six-membered hetero ring, e.g. fluorescein [3]
C12P  17/08  \	2	2	4B064	C12P  17/08	205	ʾδĤʣǴĤĤΡ㡥Υ󡤥ޥ饤ɥꥳΣ	containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons [3]
C12P  17/10  \	1	1	4B064	C12P  17/10	612	۹ึҤȤǸҤΤߤΤΡΣ	Nitrogen as only ring hetero atom [3]
C12P  17/12  \	2	2	4B064	C12P  17/12	552	ĤĤΡΣ	containing a six-membered hetero ring [3]
C12P  17/14  \	1	1	4B064	C12P  17/14	174	۹ึҤǸҤޤϻǸҤǤꡤƱˣʾΰۤʤ۹ึҤĤΡΣ	Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring [3]
C12P  17/16  \	1	1	4B064	C12P  17/16	532	ʾʣǴĤĤΡΣ	containing two or more hetero rings [3]
C12P  17/18  \	1	1	4B064	C12P  17/18	1175	ʾʣǴĤߤ˽̹ޤ϶̤úǴĤȽ̹礷¤ĤΡ㡥եޥΣ	containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin [3]
C12P  17/18  A	1	0	4B064	C12P  17/18	181	۹ึҤΣĤν̹ʣǴ	Condensed hetero rings with N1 hetero atoms
C12P  17/18  B	1	0	4B064	C12P  17/18	364	۹ึҤΣİʾν̹ʣǴ	Condensed hetero rings with N2 or more hetero atoms
C12P  17/18  C	1	0	4B064	C12P  17/18	417	۹ึҤȤƣΤȣϤΤߤޤ̹ʣǴ	Condensed hetero rings having only N and O as hetero atoms
C12P  17/18  D	1	0	4B064	C12P  17/18	460	۹ึҤȤƣϤΤߤޤ̹ʣǴ	Condensed hetero rings having only  O as hetero atoms
C12P  17/18  Z	1	0	4B064	C12P  17/18	127	¾Τ	Others
C12P  19/00  \	0	0	4B064	C12P  19/00	901	ޤಽʪ¤ʥȥɥãУˡΣ	Preparation of compounds containing saccharide radicals (ketoaldonic acids C12P  7/58)
C12P  19/02  \	1	1	4B064	C12P  19/02	1226	ñΣ	Monosaccharides [3]
C12P  19/04  \	1	1	4B064	C12P  19/04	979	¿ࡤʤʾ𤬥ꥳɷˤäƸߤ˷礷ʪΣ	Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds [3]
C12P  19/04  A	1	0	4B064	C12P  19/04	230	ôҶݤफΤ	Of fungus origin (excluding basidiomycete)
C12P  19/04  B	1	0	4B064	C12P  19/04	251	ôҶݤΤ	Of  basidiomycete origin
C12P  19/04  C	1	0	4B064	C12P  19/04	967	ٶݡ㡥ݡΤ	Of bacteria origin (including ray fungus)
C12P  19/04  Z	1	0	4B064	C12P  19/04	599	¾Τ	Of other origin
C12P  19/06  \	2	2	4B064	C12P  19/06	155	󥿥󡤤ʤȥʥΥإƥ¿Σ	Xanthan, i.e. Xanthomonas-type heteropolysaccharides [3]
C12P  19/08  \	2	2	4B064	C12P  19/08	39	ǥȥΣ	Dextran [3]
C12P  19/10  \	2	2	4B064	C12P  19/10	30	ץΣ	Pullulan [3]
C12P  19/12  \	1	1	4B064	C12P  19/12	571	Σ	Disaccharides [3]
C12P  19/14  \	1	1	4B064	C12P  19/14	348	ܥҥɥ顼κѤˤ¤㡥ߥ顼ˤΡΣ	produced by the action of a carbohydrase, e.g. by alpha-amylase [3]
C12P  19/14  A	1	0	4B064	C12P  19/14	901	ʪȤ	Having cellulose substance as matrix
C12P  19/14  Z	1	0	4B064	C12P  19/14	909	¾Τ	Others
C12P  19/16  \	1	1	4B064	C12P  19/16	265	ݣݥ륳κѤˤ¤㡥ߥڤꥢߥڥΣ	produced by the action of an alpha-1, 6-glucosidase, e.g. amylose, debranched amylopectin [3]
C12P  19/18  \	1	1	4B064	C12P  19/18	775	ꥳȥ󥹥ե顼κѤˤ¤㡥¡ޤϦáǥȥΣ	produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins [3]
C12P  19/20  \	1	1	4B064	C12P  19/20	214	륳κѤˤ¤㡥ǥȥΣ	produced by the action of an exo-1, 4 alpha-glucosidase, e.g. dextrose [3]
C12P  19/22  \	1	1	4B064	C12P  19/22	186	¡ߥ顼κѤˤ¤㡥Σ	produced by the action of a beta-amylase, e.g. maltose [3]
C12P  19/24  \	1	1	4B064	C12P  19/24	285	顼κѤˤ¤㡥Σ	produced by the action of an isomerase, e.g. fructose [3]
C12P  19/26  \	1	1	4B064	C12P  19/26	773	Ǥޤú岽ʪ¤Σ	Preparation of nitrogen-containing carbohydrates [3]
C12P  19/28  \	2	2	4B064	C12P  19/28	211	ΡꥳɡΣ	N-glycosides [3]
C12P  19/30  \	3	3	4B064	C12P  19/30	283	̥쥪ɡΣ	Nucleotides [3]
C12P  19/32  \	4	4	4B064	C12P  19/32	847	ƱˣĤǸҤͭ룶Ĥޤ̹ķϤĤΡ㡥ץ̥쥪ɡ˥󥢥ߥɡǥ˥󥸥̥쥪ɡΣ	having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide [3]
C12P  19/34  \	4	4	4B064	C12P  19/34	268	ݥ̥쥪ɡ㡥˻ꥴܥ̥쥪ɡΣ	Polynucleotides, e.g. nucleic acids, oligoribonucleotides [3]
C12P  19/34  A	4	0	4B064	C12P  19/34	801	ҹؤ˴ؤ	Related to genetic engineering
C12P  19/34  Z	4	0	4B064	C12P  19/34	321	¾Τ	Others
C12P  19/36  \	4	4	4B064	C12P  19/36	156	̥쥪ɡ㡥˥󥢥ߥɡǥ˥󥸥̥쥪ɥۥեȡΣ	Dinucleotides, e.g. nicotineamide-adenine dinucleotide phosphate [3]
C12P  19/38  \	3	3	4B064	C12P  19/38	228	̥쥪ɡΣ	Nucleosides [3]
C12P  19/40  \	4	4	4B064	C12P  19/40	551	ƱˣĤǸҤģĤޤ̹ķϤĤΡ㡥ץ̥쥪ɡΣ	having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides [3]
C12P  19/42  \	3	3	4B064	C12P  19/42	152	Хߥ󡤤ʤӥߥ¢̣̣İҡΣ	Cobalamins, i.e. vitamin B<sub>12</sub>, LLD factor [3]
C12P  19/44  \	1	1	4B064	C12P  19/44	853	ϡꥳɤ¤㡥륳ɡΣ	Preparation of O-glycosides, e.g. glucosides [3]
C12P  19/46  \	2	2	4B064	C12P  19/46	44	إ˷礹λǸҤĤΡ㡥ޥΣ	having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin [3]
C12P  19/48  \	3	3	4B064	C12P  19/48	155	إ𤬣İʾǸҤִƤΡ㡥ǥȥޥ󡤥ͥߥΣ	the cyclohexyl radical being substituted by two or more nitrogen atoms, e.g. destomycin, neamin [3]
C12P  19/50  \	4	4	4B064	C12P  19/50	39	إܤúǸҤ˻ǸҤˤäƤΤ߷礹룲ĤĤΡ㡥֥󡤥ܥޥΣ	having two saccharide radicals bound through only oxygen to adjacent ring carbon atoms of the cyclohexyl radical, e.g. ambutyrosin, ribostamycin [3]
C12P  19/52  \	5	5	4B064	C12P  19/52	18	ʾĤΡ㡥ͥޥ󡤥ӥɥޥΣ	containing three or more saccharide radicals, e.g. neomycin, lividomycin [3]
C12P  19/54  \	3	3	4B064	C12P  19/54	57	إ𤬣ʾΡֿޡ״ǸҤľܷ礷Ρ㡥ȥץȥޥΣ	the cyclohexyl radical being bound directly to a nitrogen atom of two or more [figure] radicals, e.g. streptomycin [3]
C12P  19/56  \	2	2	4B064	C12P  19/56	335	λǸҤʾúǴĤĽ̹ķϤľܷ礹Ρ㡥Υޥ󡤥ɥꥢޥΣ	having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin [3]
C12P  19/58  \	2	2	4B064	C12P  19/58	82	λǸҤʣǴļľúǸҤΤߤˤäľܷ礹Ρ㡥֥쥪ޥ󡤥ե쥪ޥΣ	having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin [3]
C12P  19/60  \	2	2	4B064	C12P  19/60	266	λǸҤʣǴļޤʣǴļޤ̹ķϤľܷ礹Ρ㡥ޥ󡤥ΥܥӥΣ	having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin [3]
C12P  19/62  \	3	3	4B064	C12P  19/62	348	ʣǴĤʾδĤǤꡤ۹ĸҤȤƻǸҤΤߤĤΡ㡥ꥹޥ󡤥ԥޥ󡤥ʥΣ	the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin [3]
C12P  19/64  \	1	1	4B064	C12P  19/64	26	ӡꥳɤ¤㡥󥳥ޥΣ	Preparation of S-glycosides, e.g. lincomycin [3]
C12P  21/00  \	0	0	4B064	C12P  21/00	3639	ڥץɤޤ¤ñ˦ãΣˡΣ	Preparation of peptides or proteins (single-cell protein C12N 1/00) [3]
C12P  21/00  A	0	0	4B064	C12P  21/00	1357	¤̤ΤΥڥץɤޤϤѤ¤ʣãУáãУ̤ͥ	Preparation of peptides or proteins with unknown structure (C to L take precedence)
C12P  21/00  B	0	0	4B064	C12P  21/00	724	ʪΤΤѤʬΥʣãУáãУ̤ͥ	Separation, refining of protein from bacterial fungus (C to L take precedence)
C12P  21/00  C	0	0	4B064	C12P  21/00	2579	ҹؤ˴ؤΡʣãУšãУ̤ͥ	Related to genetic engineering (E to L take precedence)
C12P  21/00  E	0	0	4B064	C12P  21/00	42	󥷥	Insulin
C12P  21/00  F	0	0	4B064	C12P  21/00	262	󥿡ե	Interferon
C12P  21/00  G	0	0	4B064	C12P  21/00	18	륿	Glutathione
C12P  21/00  H	0	0	4B064	C12P  21/00	198	ĹҡĹۥ	Growth factors, growth hormones
C12P  21/00  K	0	0	4B064	C12P  21/00	213	ۥ㡥󥿡	Lymphokine (interleukin)
C12P  21/00  L	0	0	4B064	C12P  21/00	72	ۥȥ󡤣ԣΣ	Lymphotoxin, TNF
C12P  21/00  Z	0	0	4B064	C12P  21/00	210	¾	Others
C12P  21/02  \	1	1	4B064	C12P  21/02	6279	ʾΥߥληΤΤΡ㡥륿Σ	having a known sequence of two or more amino acids, e.g. glutathione [3]
C12P  21/02  A	1	0	4B064	C12P  21/02	1508	¤ΤΥڥץɤޤϤѤ¤ʣãУáãУ̤ͥ	Preparation of peptides or proteins with known structure (C to M take precedence)
C12P  21/02  B	1	0	4B064	C12P  21/02	658	ǹѤˤڥץɤ¤ʣãУáãУ̤ͥ	Preparation of peptides using enzyme synthesis action (C to M take precedence)
C12P  21/02  C	1	0	4B064	C12P  21/02	19525	ҹؤ˴ؤΡʣãУšãУ̤ͥ	Related to genetic engineering (E to M take precedence)
C12P  21/02  E	1	0	4B064	C12P  21/02	267	󥷥	Insulin
C12P  21/02  F	1	0	4B064	C12P  21/02	426	󥿡ե	Interferon
C12P  21/02  G	1	0	4B064	C12P  21/02	148	륿	Glutathione
C12P  21/02  H	1	0	4B064	C12P  21/02	958	ĹҡĹۥ	Growth factors, growth hormones
C12P  21/02  K	1	0	4B064	C12P  21/02	635	ۥ㡥󥿡	Lymphokine (interleukin)
C12P  21/02  L	1	0	4B064	C12P  21/02	189	ۥȥ󡤣ԣΣ	Lymphotoxin, TNF
C12P  21/02  Z	1	0	4B064	C12P  21/02	419	¾	Others
C12P  21/04  \	2	2	4B064	C12P  21/04	394	ľޤϲͶΥڥץɤޤϥݥڥץɡ㡥Хȥ饷Σ	Cyclic or bridged peptides or polypeptides e.g. bacitracin
C12P  21/06  \	1	1	4B064	C12P  21/06	1262	ڥץɷβÿʬˤ¤㡥ÿʬʪΣ	produced by the hydrolysis of a peptide bond, e.g. hydrolysate products [3]
C12P  21/08  \	1	1	4B064	C12P  21/08	23323	Υʥ빳ΡΣ	Monoclonal antibodies [5]
C12P  23/00  \	0	0	4B064	C12P  23/00	499	ŷˤäƷ礷Ƥ뾯ʤȤ⣱ĤúǸҤޤ˰¦ĥإĤޤಽʪ¤㡥ʣǴĤޤΣãУˡΣ	Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes (containing hetero-rings C12P 17/00) [3]
C12P  25/00  \	0	0	4B064	C12P  25/00	159	ޤϥˤĲʪ¤㡥ܥեӥΣ	Preparation of compounds containing alloxazine or isoalloxazine nucleus, e.g. riboflavin [3]
C12P  27/00  \	0	0	4B064	C12P  27/00	8	Хʤޤಽʪ¤㡥٥Σ	Preparation of compounds containing a gibbane ring system, e.g. gibberellin [3]
C12P  29/00  \	0	0	4B064	C12P  29/00	156	ʥեʤޤಽʪ¤㡥ƥȥ饵ʣãУͥˡΣ	Preparation of compounds containing a naphthacene ring system, e.g. tetracycline (C12P 19/00 takes precedence) [3]
C12P  31/00  \	0	0	4B064	C12P  31/00	55	ߤ˥Ȱ̤ˤ룲Ĥȡ¦ΣĤФ륪Ȱ̤˴Ĥľܷ礹뾯ʤȤ⣱ĤλǸҤģĤͭ벽ʪǤäơΣĤ¦ϰۼ︶ҤФ룳ĤηͭΤ磱ĤηϥϥФǤúǸҤǤäƴĤľܷ礷ʤΤޤߡ¾¦ϴĤФƦá̤˷礹ǸҤ򾯤ʤȤ⣱Ļäʪ¤㡥ץ󥸥Σ	Preparation of compounds containing a five-membered ring having two side-chains in ortho position to each other, and having at least one oxygen atom directly bound to the ring in ortho position to one of the side-chains, one side-chain containing, not directly bound to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having at least one oxygen atom bound in gamma-position to the ring, e.g. prostaglandins [3]
C12P  33/00  \	0	0	4B064	C12P  33/00	306	ƥɤ¤Σ	Preparation of steroids
C12P  33/02  \	1	1	4B064	C12P  33/02	151	æǲæ𲽡Σ	Dehydrogenating; Dehydroxylating [3]
C12P  33/04  \	2	2	4B064	C12P  33/04	7	Ĥ饢꡼ĤΣ	Forming an aryl ring from A ring [3]
C12P  33/06  \	1	1	4B064	C12P  33/06	142	Σ	Hydroxylating [3]
C12P  33/08  \	2	2	4B064	C12P  33/08	64	̤ˡΣ	at 11 position [3]
C12P  33/10  \	3	3	4B064	C12P  33/10	21	̤ˡΣ	at 11alpha-position [3]
C12P  33/12  \	1	1	4B064	C12P  33/12	34	ĴĤؤκѡΣ	Acting on D ring [3]
C12P  33/14  \	2	2	4B064	C12P  33/14	13	̤οΣ	Hydroxylating at 16 position [3]
C12P  33/16  \	2	2	4B064	C12P  33/16	180	̤ؤκѡΣ	Acting at 17 position [3]
C12P  33/18  \	3	3	4B064	C12P  33/18	36	̤οΣ	Hydroxylating at 17 position [3]
C12P  33/20  \	1	1	4B064	C12P  33/20	78	ʣǴĤĤΡΣ	containing heterocyclic rings [3]
C12P  35/00  \	0	0	4B064	C12P  35/00	104	ӥ̣ͥķϤĲʪ¤㡥եݥΣ	Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin [3]
C12P  35/02  \	1	1	4B064	C12P  35/02	59	̤ˤִæ벽ˤΡΣ	by desacylation of the substituent in the 7 position [3]
C12P  35/04  \	1	1	4B064	C12P  35/04	84	̤ˤִΥ벽ˤΡΣ	by acylation of the substituent in the 7 position [3]
C12P  35/06  \	1	1	4B064	C12P  35/06	96	եݥáͶƳΡΣ	Cephalosporin C; Derivatives thereof [3]
C12P  35/08  \	1	1	4B064	C12P  35/08	72	̤ˤ룲ִΡΣ	disubstituted in the 7 position [3]
C12P  37/00  \	0	0	4B064	C12P  37/00	102	ӥ̣ͥإץķϤĲʪ¤㡥ڥ˥Σ	Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin [3]
C12P  37/02  \	1	1	4B064	C12P  37/02	12	ե˥ݻե˥ݻߥɤޤϤͶƳΤ¸߲Σ	in presence of phenylacetic acid or phenylacetamide or their derivatives [3]
C12P  37/04  \	1	1	4B064	C12P  37/04	54	ִ̤Υ벽ˤΡΣ	by acylation of the substituent in the 6 position [3]
C12P  37/06  \	1	1	4B064	C12P  37/06	64	ִ̤æ벽ˤΡΣ	by desacylation of the substituent in the 6 position [3]
C12P  39/00  \	0	0	4B064	C12P  39/00	116	Ʊ칩Ʊ˰ۤʤäʪޤˡΣ	Processes involving micro-organisms of different genera in the same process, simultaneously [3]
C12P  41/00  \	0	0	4B064	C12P  41/00	972	ǤޤʪѤƥ饻ߺʪذΤʬΥˡΣ	Processes using enzymes or micro-organisms to separate optical isomers from a racemic mixture [4]
C12P  41/00  A	0	0	4B064	C12P  41/00	407	ߥλ¥ߥλޤϤͶƳΤʬΥ	Separating a or b amino acid (including derivatives)
C12P  41/00  B	0	1	4B064	C12P  41/00	71	Ĥβÿʬˤ	By hydrolysis of the ring
C12P  41/00  C	0	0	4B064	C12P  41/00	352	áȡϡϥʳθǤޤޤʤ饻ߺʪΤ	From racemic mixture not containing elements other than C, H, O, halogen
C12P  41/00  D	0	1	4B064	C12P  41/00	234	饻ߥƥ뺮ʪΤ	From racemic ester mixture
C12P  41/00  E	0	2	4B064	C12P  41/00	201	ļ饻ߺʪΤ	From ring racemic mixture
C12P  41/00  F	0	3	4B064	C12P  41/00	235	˧²饻ߺʪΤ	From aromatic racemic mixture
C12P  41/00  G	0	3	4B064	C12P  41/00	66	̹úǣĥ饻ߺʪΤ	From non-condensed carbon five-membered racemic mixture
C12P  41/00  H	0	0	4B064	C12P  41/00	252	δͭ饻ߺʪΤΡʣãУãУͥ	From racemic mixture containing N
C12P  41/00  J	0	1	4B064	C12P  41/00	344	ļ饻ߺʪΤ	From ring racemic mixture
C12P  41/00  K	0	0	4B064	C12P  41/00	147	áȡϡΡϥʳθǴͭ饻ߺʪΤ	From racemic mixture containing elements other than C, H, O, N, halogen (salt is classified under matrix compound)
C12P  41/00  Z	0	0	4B064	C12P  41/00	207	¾Τ	Others
